Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17760
Abstract: Immune checkpoint inhibitors (ICIs) have dramatically changed the prognosis of advanced melanoma patients, but also exposed them to immune-related adverse events (irAEs).1 Furthermore, with the combination ipilimumab (IPI) plus nivolumab (NIVO) some rare irAEs, such…
read more here.
Keywords:
advanced melanoma;
covid;
plus nivolumab;
severe necrotizing ... See more keywords